Totally (TLY) Competitors

GBX 8.25
-0.50 (-5.71%)
(As of 05/15/2024 ET)

TLY vs. KNB, CHLL, BELL, ABDX, STX, GENI, SNG, INHC, IHC, and PXS

Should you be buying Totally stock or one of its competitors? The main competitors of Totally include Kanabo Group (KNB), Chill Brands Group (CHLL), Belluscura (BELL), Abingdon Health (ABDX), Shield Therapeutics (STX), GENinCode (GENI), Synairgen (SNG), Induction Healthcare Group (INHC), Inspiration Healthcare Group (IHC), and Provexis (PXS). These companies are all part of the "medical" sector.

Totally vs.

Kanabo Group (LON:KNB) and Totally (LON:TLY) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, media sentiment, risk, valuation, profitability, community ranking, analyst recommendations and institutional ownership.

Kanabo Group has a beta of 3.15, suggesting that its stock price is 215% more volatile than the S&P 500. Comparatively, Totally has a beta of 0.52, suggesting that its stock price is 48% less volatile than the S&P 500.

Totally received 129 more outperform votes than Kanabo Group when rated by MarketBeat users.

CompanyUnderperformOutperform
Kanabo GroupN/AN/A
TotallyOutperform Votes
129
72.47%
Underperform Votes
49
27.53%

Totally has higher revenue and earnings than Kanabo Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kanabo Group£1K10,188.45-£7.99M-£0.01-161.10
Totally£121.20M0.13£1.78MN/AN/A

3.8% of Kanabo Group shares are owned by institutional investors. Comparatively, 34.8% of Totally shares are owned by institutional investors. 45.3% of Kanabo Group shares are owned by company insiders. Comparatively, 12.4% of Totally shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Kanabo Group has a net margin of 0.00% compared to Kanabo Group's net margin of -0.80%. Kanabo Group's return on equity of -2.72% beat Totally's return on equity.

Company Net Margins Return on Equity Return on Assets
Kanabo GroupN/A -80.16% -18.89%
Totally -0.80%-2.72%0.30%

Totally has a consensus target price of GBX 30, indicating a potential upside of 258.25%. Given Kanabo Group's higher possible upside, analysts clearly believe Totally is more favorable than Kanabo Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kanabo Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Totally
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Totally had 2 more articles in the media than Kanabo Group. MarketBeat recorded 2 mentions for Totally and 0 mentions for Kanabo Group. Kanabo Group's average media sentiment score of 0.65 beat Totally's score of 0.00 indicating that Totally is being referred to more favorably in the news media.

Company Overall Sentiment
Kanabo Group Neutral
Totally Positive

Summary

Totally beats Kanabo Group on 10 of the 15 factors compared between the two stocks.

Get Totally News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLY vs. The Competition

MetricTotallyMedical Care Facilities IndustryMedical SectorLON Exchange
Market Cap£16.22M£1.19B£5.09B£1.46B
Dividend Yield13.16%3.94%37.04%10.67%
P/E Ratio-515.00272.09134.931,630.49
Price / Sales0.1363,712.272,301.30313,269.13
Price / Cash9.0812.8135.7833.58
Price / Book0.462.235.492.74
Net Income£1.78M£35.11M£104.62M£177.36M
7 Day Performance32.00%2.37%1.25%1.09%
1 Month Performance79.39%3.67%2.75%7.86%
1 Year Performance-61.81%-6.07%6.93%8.68%

Totally Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KNB
Kanabo Group
0 of 5 stars
GBX 1.75
-5.4%
N/A-37.8%£11.07M£1,000.00-175.0023Gap Down
CHLL
Chill Brands Group
0 of 5 stars
GBX 2.55
+10.9%
N/A-57.5%£12.91M£624,187.00-255.007
BELL
Belluscura
0 of 5 stars
GBX 8
+3.2%
N/A-71.9%£13.15M£1.20M-133.3324Gap Down
ABDX
Abingdon Health
0 of 5 stars
GBX 10.50
+7.7%
N/A+16.4%£12.78M£5.34M-1,050.0084Gap Down
STX
Shield Therapeutics
0 of 5 stars
GBX 1.58
+1.3%
N/A-74.4%£12.32M£7.40M-13.1327
GENI
GENinCode
0 of 5 stars
GBX 7.88
+6.8%
N/A-46.7%£13.94M£1.72M-131.2534Gap Up
SNG
Synairgen
0 of 5 stars
GBX 5.91
-4.7%
N/A-34.1%£11.90M£79,000.00-118.2034Gap Up
INHC
Induction Healthcare Group
0 of 5 stars
GBX 12.50
flat
N/A-46.7%£11.55M£11.82M-83.3383Gap Down
IHC
Inspiration Healthcare Group
0 of 5 stars
GBX 16.75
flat
N/A-64.8%£11.43M£41.08M-1,675.00210Gap Down
PXS
Provexis
0 of 5 stars
GBX 0.65
flat
N/A-24.3%£14.69M£426,168.0043.752High Trading Volume

Related Companies and Tools

This page (LON:TLY) was last updated on 5/15/2024 by MarketBeat.com Staff

From Our Partners